FindTrial
Sign In

A prospective clinical registration study on the real world efficacy of Angong Niuhuang Pill

A prospective clinical registration study on the real world efficacy of Angong Niuhuang Pill

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2200005593
Enrollment
Unknown
Registered
2022-02-03
Start date
2022-02-07
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

Exposed group:Routine treatment + Angong niuhuang pill
Non exposed group:routine treatment

Sponsors

Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All patients diagnosed and prescribed angong bezoar pills by clinicians (investigators) enrolled in the study

Exclusion criteria

Exclusion criteria: Patients deemed unsuitable for enrollment by the investigator.

Design outcomes

Primary

MeasureTime frame
Changes in body temperature and duration of high fever/fever;Wake up and correct the outcome and time of coma;Ischemic stroke syndrome Factors Diagnostic Scale;Coma scale;The outcome and time required for signs to return to normal;GOS(Glasgow outcome Scale) score and NIHSS(National Institutes of Health Stroke Scale) score changes before, after and 1 month after medication;CT and MRI indicated that cerebral hemorrhage was reduced and absorbed, and cerebral infarction was reduced;—

Secondary

MeasureTime frame
Changes in serological tests;Changes of lumbar puncture detection indexes;Changes in respiratory tract specimens;—

Countries

China

Contacts

Public ContactLiu Jia
marie_liujia@sina.cn18810877011

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026